"We will fix the ceiling prices of over 300 formulations based on bulk drugs by the end of this month. This would include around 237 formulations the ceiling prices of which we have already fixed," National Pharmaceutical Pricing Authority (NPPA) Chairman C P Singh told PTI.
According to industry experts, the implementation of the new drug policy could lead to slashing of prices of many anti-cancer and anti-infective drugs by 50-80 per cent.
The new order is set to regulate the prices of 348 essential drugs listed in the National List of Essential Medicines (NLEM). Earlier, Drug Prices Control Order 1995 regulated prices of only 74 bulk drugs.
As per the new drugs policy, all strengths and dosages specified in NLEM 2011 will be under price control.
According to the approved policy, prices of medicines will now be capped by taking simple average of all brands which have more than one per cent market share instead of input costs.
As per the DPCO 2013, issued under the Essential Commodities Act, 1955, NPPA is the implementation authority for the new policy.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
